N6-2-(4-aminophenyl) ethyl-adenosine enhances the anticonvulsive activity of antiepileptic drug

European Journal of Pharmacology

Volumn 327, Issue 2-3, 1997, Pages 125-133

  Borowicz, Kinga K ^a   Kleinrok, Zdzisław ^a   Czuczwar, Stanisław J ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Adenosine A3 receptor; Adenosine receptor; Antiepileptic drug; APNEA (N6 2 (4 aminophenyl)ethyl adenosine); Maximal electroshock; Seizure

Indexed keywords

2 (4 AMINOPHENYL)ETHYL ADENOSINE; ADENOSINE A3 RECEPTOR; ADENOSINE RECEPTOR; AMINOPHYLLINE; ANTICONVULSIVE AGENT; CARBAMAZEPINE; PHENOBARBITAL; PHENYTOIN; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG; VALPROIC ACID; ADENOSINE; DRUG DERIVATIVE; N(6) 2 (4 AMINOPHENYL)ETHYLADENOSINE; N(6)-2-(4-AMINOPHENYL)ETHYLADENOSINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY TEMPERATURE; CONTROLLED STUDY; CONVULSION; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG POTENTIATION; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; MEMORY; MOUSE; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; ANIMAL; DARKNESS; DRUG EFFECT; ELECTRIC SHOCK; MOTOR ACTIVITY;

ADENOSINE; ANIMALS; ANTICONVULSANTS; BODY TEMPERATURE; CARBAMAZEPINE; DARKNESS; DRUG SYNERGISM; ELECTROSHOCK; FEMALE; MEMORY; MICE; MOTOR ACTIVITY; PHENOBARBITAL; PHENYTOIN; RECEPTORS, PURINERGIC P1; VALPROIC ACID;

EID: 0030611565     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)89651-3     Document Type: Article

References (38)

1. Barraco R.A., Coffin V.L., Altman H.J., Phillis J.W. Central effects of adenosine analogs on locomotor activity in mice and antagonism of caffeine. Brain Res. 272:1983;392-396.
2. Boissier J.R., Tardy J., Diverres J.S. Une nouvelle méthode simple pour explorer l'action tranquillisante: le test de la cheminée. Med. Exp. (Basel). 3:1960;81-84.
3. Borowicz K.K., Kozicka M., Kleinrok Z., Czuczwar S.J. Influence of 8-(p-sulfophenyl)theophylline on the anticonvulsant action of diphenylhydantoin, phenobarbital, and valproate against maximal electroshock-induced convulsions in mice. J. Neural Transm. 93:1993;157-163.
4. Collis M.G., Hourani S.M.O. Adenosine receptors subtypes. Trends Pharmacol. Sci. 14:1993;360-365.
5. Czuczwar S.J., Kleinrok Z. Modulation of the protective efficacy of common antiepileptic drugs by xanthine derivatives: implications for the clinical use of xanthines in epileptic patients. Pharmacol. Res. 22:1990;661-665.
6. Czuczwar S.J., Ikonomidou C., Kleinrok Z., Turski L., Turski W.A. Effects of aminophylline on the protective action of common antiepileptic drugs against electroconvulsions in mice. Epilepsia. 27:1986;204-208.
7. Czuczwar S.J., Jäckel R., Löscher W. Effects of aminophylline and enprofylline on the protective action of phenobarbital against kindled seizures in rats. Epilepsy Res. 1:1987;234-238.
8. Czuczwar S.J., Janusz W., Szczepanik B., Wamil A., Kleinrok Z. Effects of aminophylline upon the protective activity of common antiepileptic drugs and their plasma levels in mice. Neurosci. Res. 6:1989;470-474.
9. Czuczwar S.J., Szczepanik B., Wamil A., Janusz W., Kleinrok Z. Differential effects of agents enhancing purinergic transmission upon the antielectroshock efficacy of carbamazepine, diphenylhydantoin, diazepam, phenobarbital, and valproate in mice. J. Neural Transm. 81:1990;153-166.
10. Daly J.W., Bruns R.F., Snyder S.H. Adenosine receptors in the central nervous system; relationship to the central actions of methylxanthines. Life Sci. 28:1981;2083-2097.
11. Dragunow, M., 1991. Adenosine and epileptic seizures. In: Phillis, J.W. (Ed.), Adenosine and Adenine Nucleotides as Regulators of Cellular Functions. CRC Press, Boca Raton, FL, pp. 367-376.
12. Dunwiddie T.V., Worth T. Sedative and anticonvulsant effects of adenosine analogs in mouse and rat. J. Pharmacol. Exp. Ther. 220:1982;70-76.
13. During M.J., Spencer D.P. Adenosine; a potential mediator of seizure arrest and postictal refractoriness. Ann. Neurol. 32:1992;618-624.
14. 3 mediate hypotension in the angiotensin II supported circulation of the pitched rat. Br. J. Pharmacol. 109:1993;3-5.
15. 2 receptors. Psychopharmacology. 90:1986;332-335.
16. 3 noradrenaline from slices of rat brain neocortex. Eur. J. Pharmacol. 49:1978;305-309.
17. 3 adenosine receptors: mediation of behavioral depressant effects. FEBS Lett. 336:1993;57-63.
18. 3 adenosine receptors: design of selective ligands and therapeutic prospects. Drugs Future. 20:1995;689-699.
19. Levine A.S., Morely J.E. Purinergic modulation of food intake. Science. 217:1982;77-81.
20. 3 receptors: pharmacological properties, species differences and receptor functions. Trends Pharmacol. Sci. 15:1994;298-304.
21. Litchfield J.T., Wilcoxon F. A simplified method of evaluating dose-effect experiments. J. Pharmacol. Exp. Ther. 96:1949;99-113.
22. Marangos, P.J. and Miller, L., 1991. Adenosine-based therapeutics in neurologic disease. In: Phillis, J.W. (Ed.), Adenosine and Adenine Nucleotides as Regulators of Cellular Function. CRC Press, Boca Raton, FL, pp. 413-422.
23. Phillis J.W. Interactions of the anticonvulsants diphenylhydantoin and carbamazepine with adenosine on cerebral cortical neurons. Epilepsia. 25:1984;765-772.
24. Ribeiro, J.A., 1991. Purinergic regulation of transmitter release. In: Phillis, J.W. (Ed.), Adenosine and Adenine Nucleotides as Regulators of Cellular Function. CRC Press, Boca Raton, FL, pp. 155-165.
25. Skerrit J.H., Davies L.P., Johnston G.A.R. A purinergic component in the anticonvulsant carbamazepine. Eur. J. Pharmacol. 82:1982;195-197.
26. Skerrit J.H., Davies L.P., Johnston G.A.R. Interactions of the anticonvulsant carbamazepine with adenosine receptors. 1. Neurochemical studies Epilepsia. 24:1983;634-642.
27. Swinyard E.A., Brown W.C., Goodman L.S. Comparative assays of antiepileptic drugs in mice and rats. J. Pharmacol. Exp. Ther. 106:1952;319-330.
28. Van Calker D., Mullerand M., Hamprecht B. Adenosine regulates via two different types of receptors the accumulation of cyclic AMP in cultured brain cells. J. Neurochem. 33:1979;999-1005.
29. Venault P., Chapouthier G., De Carvalho L.P., Simiand J., Morre M., Dodd R.H., Rossier J. Benzodiazepines impair and beta-carbolines enhance performance in learning and memory task. Nature. 321:1986;864-866.
30. Von Lubitz, D.K.J.E. and Marangos, P.J., 1992. Self-defense on the brain: adenosinergic strategies in neurodegeneration. In: Marangos, P.J., Lal, H. (Eds.), Emerging Strategies in Neuroprotection. Birkhäuser, Boston, MA, pp. 151-157.
31. 3 receptor stimulation and cerebral ischemia. Eur. J. Pharmacol. 263:1994;59-67.
32. 3 receptor stimulation on seizures in mice. Eur. J. Pharmacol. 275:1995;23-29.
33. Weir R.L., Padgett W., Daly J.W., Anderson S.M. Interaction of anticonvulsant drugs with adenosine receptors in the central nervous system. Epilepsia. 25:1984;492-498.
34. Williams M., Francis J., Braunwalder G.G., Psychoyos S., Stone G.A., Cash W.D. Biochemical characterization of the triazoloquinazoline, CGS 15943A, a novel, nonxanthine adenosine antagonist. J. Pharmacol. Exp. Ther. 241:1987;415-420.
35. Yarbrough G.C., McGuffin J.C. In vivo behavioral assessment of central nervous system purinergic receptors. Eur. J. Pharmacol. 76:1981;137-142.
36. Young D., Dragunow M. Status epilepticus may be caused by loss of adenosine anticonvulsant mechanisms. Neurosci. 58:1994;245-261.
37. Zarrindast M.R., Bijan S. Effects of adenosine receptor agonists and antagonists on acquisition of passive avoidance learning. Eur. J. Pharmacol. 256:1994;233-239.
38. Zarrindast M.R., Heidari M.R. Involvement of adenosine receptors in mouse thermoregulation. J. Psychopharmacol. 7:1993;365-369.